Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.550
-0.010 (-0.39%)
At close: Dec 5, 2025, 4:00 PM EST
2.589
+0.039 (1.52%)
After-hours: Dec 5, 2025, 7:55 PM EST
Cabaletta Bio Employees
As of December 31, 2024, Cabaletta Bio had 164 total employees, including 161 full-time and 3 part-time employees. The number of employees increased by 61 or 59.22% compared to the previous year.
Employees
164
Change (1Y)
61
Growth (1Y)
59.22%
Revenue / Employee
n/a
Profits / Employee
-$966,604
Market Cap
245.48M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CABA News
- 2 days ago - Cabaletta Bio, Inc. (CABA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 26 days ago - Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December - GlobeNewsWire
- 5 weeks ago - Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025 - GlobeNewsWire
- 7 weeks ago - Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant - GlobeNewsWire
- 2 months ago - Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress - GlobeNewsWire
- 2 months ago - Cabaletta Bio: Still Optimistic, With News Being Guided To Be Shared Soon - Seeking Alpha
- 3 months ago - Cabaletta Bio to Participate in Upcoming Investor Conferences in September - GlobeNewsWire